WALTHAM, Mass., November 08, 2024--Global Partners LP (NYSE: GLP) ("Global" or the "Partnership") today reported financial results for the third quarter ended September 30, 2024. WALTHAM ...
Highlights,Global Partners surpasses its 200-day moving average.,The stock shows a steady rise with a 0.8% increase.,A dividend increase adds confidence to the company's financial strength.,Global ...
For patients who have been paying for Ozempic or other glucagon-like peptide-1 medications, there may be another beneficial development: On December 23, the U.S. Food and Drug Administration (FDA) ...
(MENAFN- PR Newswire) This first of its kind GLP-1 gummy provides the same active ingredient as compounded semaglutide, making it easier than ever for individuals to incorporate this medication ...
“I’m on Wegovy for the rest of my life, but I can show you an entire medicine cabinet full of medications that I no longer have to take,” said Taryn Mitchell, 53, a GLP-1 patient in ...
Amylyx Pharmaceuticals Inc. has entered into a collaboration with Gubra A/S to develop a novel long-acting GLP-1 receptor antagonist. This partnership involves Amylyx making upfront and research ...
Righting the ship on supply Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive signals” are emerging when it comes to the ...
Global GP LLC, the general partner of Global Partners LP (NYSE:GLP), recently purchased common units valued at $290,220, according to a filing with the Securities and Exchange... Global GP LLC ...
Kim Kardashian is now no longer managing the private equity firm — SKKY Partners — she co-founded in 2022 with former Carlyle Group dealmaker Jay Sammons. In a new shakeup of events in the ...